Sales Playbook
Win Every Conversation
Objection handling scripts, competitive talking points, and audience-specific messaging — all backed by clinical citations you can reference in real time.
Elevator Pitch
The Junera Story
Junera is the only dual-wavelength subdermal laser platform that delivers 980nm and 1470nm energy simultaneously through ultra-thin fiber optics (400–800μm). In a single session under local anesthesia with just 3–10 days of downtime, it tightens skin and reduces fat — backed by 15+ peer-reviewed clinical studies showing 80–100% patient satisfaction.
Junera by Onyxa Medical is a subdermal laser platform that combines two clinically validated wavelengths — 980nm for targeted fat reduction and 1470nm for collagen stimulation and skin tightening. Delivered through precision fiber optics (400μm periorbital, 600μm face/neck, 800μm body) under local anesthesia, it treats face, neck, periorbital, and body areas in a single session with 3–10 days of downtime. Clinical studies across 15+ peer-reviewed publications demonstrate 80–100% patient satisfaction, significant measurable improvements in dermis density and thickness, and a safety profile with zero serious adverse events. It fills the gap between non-invasive devices that underdeliver and surgical procedures that patients decline.
Key Differentiators
Why Junera Wins
Dual-Wavelength Synergy
Junera is the only platform delivering 980nm and 1470nm simultaneously. The 980nm targets hemoglobin and lipids for fat reduction, while the 1470nm targets water in the dermis for collagen contraction and neocollagenesis. This dual action achieves what no single-wavelength device can: simultaneous contouring and tightening.
Citation: Elicit Research, 'Aesthetic Applications of Interstitial Laser Therapy Using 980/1470nm,' Systematic review of 31 studies, 2024.
Subdermal Precision
An ultra-thin optical fiber (400–800μm depending on treatment area) delivers energy directly to the subdermal plane — beneath the skin where collagen and fat reside. This is fundamentally different from external devices (RF, ultrasound) that must penetrate through the epidermis and dermis, losing energy and precision along the way.
Citation: Bollero D et al., 'In vivo pilot study of the effects of a subdermal 1470 nm diode laser on human skin,' Aesthetic Plastic Surgery, 2014.
Single-Session Efficacy
Most competing devices require 3–6 sessions to achieve results. Junera delivers clinically significant improvement in a single treatment, with results continuing to develop over 3–6 months as collagen remodels. This means higher per-session revenue and better patient compliance.
Citation: Nilforoushzadeh MA et al., multiple studies in Journal of Cosmetic Dermatology, 2023. All demonstrated significant improvement from a single treatment session.
Short Recovery
Patients can expect 3–10 days of downtime with mild swelling, redness, and bruising that gradually resolves. Most patients return to normal activities within this window. The recovery period is significantly shorter than surgical alternatives.
Citation: Reynaud JP et al., 'Lipolysis Using a 980-nm Diode Laser: A Retrospective Analysis of 534 Procedures,' Aesthetic Plastic Surgery, 2009.
Measurable, Objective Results
Unlike many aesthetic devices that rely on subjective assessment, Junera's results have been quantified with biometric measurement: 48.75% increase in dermis density, 36.9% increase in dermis thickness, 53.78% decrease in wrinkle volume. These are numbers you can share with patients.
Citation: Nilforoushzadeh MA et al., 'Treatment of horizontal neck wrinkles by Endolift laser: Biometric measurement,' Journal of Cosmetic Dermatology, 2023.
Comprehensive Safety Profile
Across 15+ peer-reviewed studies, zero serious adverse events have been reported. The most common side effects are mild swelling and bruising that resolve within days. The systematic review of 31 studies confirmed complication rates are low and manageable when protocols are followed.
Citation: Elicit Research, 'Aesthetic Applications of Interstitial Laser Therapy Using 980/1470nm,' Systematic review of 31 studies, 2024.
Objection Handling
Competitive Responses
Click any objection to reveal the recommended response with supporting clinical citations. These are designed to be conversational, not confrontational — position Junera as complementary or superior, never dismissive of competitors.
Audience-Specific Messaging
Tailor Your Pitch
Different audiences care about different things. Select the audience type to see the most relevant talking points.
Expand Your Non-Surgical Menu
Many surgical candidates delay or decline surgery. Junera gives you a minimally invasive option that delivers real, measurable results — keeping patients in your practice rather than losing them to med spas.
Periorbital Capability
Junera is one of the few devices that can safely treat the periorbital region — upper eyelids, eyebrows, and lower eye bags — under local anesthesia. 90% improvement rates in clinical studies.
Complement Your Surgical Practice
Use Junera for touch-ups, maintenance, and patients who aren't ready for surgery. It also pairs well with surgical procedures as an adjunct for areas that benefit from additional tightening.
Quick Reference
Numbers That Close
Need More Resources?
Access the full clinical evidence, treatment protocols, and competitive comparison data across the knowledge base.